Research & Development

Is BeiGene on the Brink of Profitability with Its Blockbuster Cancer Drugs?
Research & Development Is BeiGene on the Brink of Profitability with Its Blockbuster Cancer Drugs?

BeiGene Ltd., one of China's foremost developers of next-generation cancer drugs, is on the cusp of turning a profit after years of significant investments in research and development. The company has made remarkable strides towards achieving an annual operating profit, bolstered by the

Skull Channels Unveiled: A New Frontier in Brain Health and Disease
Research & Development Skull Channels Unveiled: A New Frontier in Brain Health and Disease

A groundbreaking study conducted by Zeynep Ilgin Kolabas and her colleagues at Ludwig Maximilian University of Munich unveils the existence and function of channels between the skull and brain. This research reveals their role in trafficking immune cells and facilitating skull-specific immune

Advancing Cell Therapy: Automation and Innovations in Stem Cell Collection
Research & Development Advancing Cell Therapy: Automation and Innovations in Stem Cell Collection

The field of cell therapy is currently witnessing groundbreaking advancements, particularly in the methods of stem cell collection and the automation of manufacturing processes. These innovations hold the potential to revolutionize the sector by significantly enhancing the efficiency, reliability,

How Are Scientific Innovations Redefining Our Understanding of the World?
Research & Development How Are Scientific Innovations Redefining Our Understanding of the World?

In today's rapidly evolving scientific landscape, groundbreaking innovations are consistently transforming our understanding of the world and pushing the boundaries of what is possible. From space exploration to bioengineering, researchers are uncovering new knowledge and developing

CAR T Cell Therapy Offers Hope for Lupus Patients
Research & Development CAR T Cell Therapy Offers Hope for Lupus Patients

Lupus, a chronic autoimmune disease, has long been a challenging condition to manage, often requiring treatments that come with severe side effects and necessitate lifelong administration. However, recent advancements in Chimeric Antigen Receptor (CAR) T cell therapies are providing new hope for

Ethical Concerns Over Non-Disclosure in Alzheimer’s Drug Trials
Research & Development Ethical Concerns Over Non-Disclosure in Alzheimer’s Drug Trials

The ethical concerns surrounding the non-disclosure of genetic risks to participants in Alzheimer’s anti-amyloid drug trials have sparked significant debate. Eisai and Eli Lilly, the companies conducting these trials, were aware of the increased risk of brain swelling and bleeding in participants w

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later